We hypothesize that the differential expression of CEP55 in BC cell lines, with the highest levels in the TNBC cell line MDA-MB-231, could be attributed to tumor heterogeneity, the aggressive nature of TNBC, distinct molecular signatures, epigenetic alterations, and unique microenvironmental interactions. This evidence concerns the gene CEP55 and breast cancer.